Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cytek Biosciences (CTKB)
NASDAQ:CTKB
Holding CTKB?
Track your performance easily
Cytek Biosciences (CTKB) Ownership Overview
19.21% Insiders
17.30% Mutual Funds
36.32% Other Institutional Investors
27.16% Public Companies and
Individual Investors
The ownership structure of Cytek Biosciences (CTKB) stock is a mix of institutional, retail and individual investors. Approximately 53.62% of the company’s stock is owned by Institutional Investors, 19.21% is owned by Insiders and 27.16% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $666687 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $869135 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,227,594 | Institution | 10.06% | 69,973,972 | |
| 10,666,583 | Institution | 8.11% | 56,426,224 | |
| 9,185,493 | Institution | 6.98% | 48,591,258 | |
| 6,809,404 | Institution | 5.18% | 36,021,747 | |
| 3,895,443 | Institution | 2.96% | 20,606,893 | |
| 1,602,415 | Institution | 1.22% | 8,476,775 | |
| 1,281,433 | Institution | 0.97% | 6,778,781 | |
| 1,016,754 | Institution | 0.77% | 5,378,629 | |
| 885,368 | Institution | 0.67% | 4,683,597 | |
| 820,019 | Institution | 0.62% | 4,337,901 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,185,493 | Institution | 6.98% | 48,591,258 | |
| 3,895,443 | Institution | 2.96% | 20,606,893 | |
| 1,281,433 | Institution | 0.97% | 6,778,781 | |
| 1,016,754 | Institution | 0.77% | 5,378,629 | |
| 885,368 | Institution | 0.67% | 4,683,597 | |
| 820,019 | Institution | 0.62% | 4,337,901 | |
| 759,233 | Institution | 0.58% | 4,016,343 | |
| 618,001 | Institution | 0.47% | 3,269,225 | |
| 570,987 | Institution | 0.43% | 3,020,521 | |
| 536,757 | Institution | 0.41% | 2,839,445 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,365,906 | Institution | 4.84% | 32,211,484 | |
| 3,474,084 | Institution | 2.64% | 23,311,104 | |
| 2,647,196 | Institution | 2.01% | 17,762,685 | |
| 3,231,839 | Institution | 2.46% | 16,353,105 | |
| 1,541,217 | Institution | 1.17% | 10,341,566 | |
| 1,481,369 | Institution | 1.13% | 9,939,986 | |
| 1,146,052 | Institution | 0.87% | 5,799,023 | |
| 1,057,619 | Institution | 0.80% | 5,351,552 | |
| 851,664 | Institution | 0.65% | 4,547,886 | |
| 867,933 | Institution | 0.66% | 4,391,741 |
FAQ
Who Owns Cytek Biosciences (CTKB)?
According to the latest TipRanks data, approximately 36.32% of the company's stock is held by institutional investors, 19.21% is held by insiders, and 27.16% is held by retail investors.
What percentage of Cytek Biosciences (CTKB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.32% of Cytek Biosciences (CTKB) stock is held by institutional investors.
What percentage of Cytek Biosciences (CTKB) stock is held by retail investors?
According to the latest TipRanks data, approximately 27.16% of Cytek Biosciences (CTKB) stock is held by retail investors.
Who owns the most shares of Cytek Biosciences (CTKB)?
iShares owns the most shares of Cytek Biosciences (CTKB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.